Literature DB >> 14729251

TorsinA, the gene linked to early-onset dystonia, is upregulated by the dopaminergic toxin MPTP in mice.

Rohini Kuner1, Peter Teismann, Annette Trutzel, Jomana Naim, Angelika Richter, Nicole Schmidt, Alfred Bach, Boris Ferger, Armin Schneider.   

Abstract

Early-onset torsion dystonias are caused by a mutation in TorsinA, a protein widely expressed in the nervous system. Here we report the cloning of the murine TorsinA cDNA and a mRNA in situ hybridization analysis of the expression patterns of TorsinA over developmental periods relevant to the etiology of early-onset dystonias. Several studies have demonstrated a functional involvement of the nigrostriatal dopaminergic system in pathological mechanisms underlying dystonia. In this study, we show that the expression of TorsinA is significantly increased in the brain within hours of treatment with the dopaminergic toxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, suggesting that the TorsinA gene is regulated by cellular stress. These results provide insights into the pathophysiology of early-onset dystonia and strengthen links between the dopaminergic system and dystonia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729251     DOI: 10.1016/j.neulet.2003.10.069

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  RNA interference-mediated inhibition of wild-type Torsin A expression increases apoptosis caused by oxidative stress in cultured cells.

Authors:  Xue-Ping Chen; Xiao-Hui Hu; Shu-Hui Wu; Yang-Wei Zhang; Bo Xiao; Hui-Fang Shang
Journal:  Neurochem Res       Date:  2010-05-09       Impact factor: 3.996

2.  The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response.

Authors:  Pan Chen; Alexander J Burdette; J Christopher Porter; John C Ricketts; Stacey A Fox; Flavia C Nery; Jeffrey W Hewett; Laura A Berkowitz; Xandra O Breakefield; Kim A Caldwell; Guy A Caldwell
Journal:  Hum Mol Genet       Date:  2010-06-28       Impact factor: 6.150

3.  Exploring the influence of torsinA expression on protein quality control.

Authors:  Kara L Gordon; Kevin A Glenn; Pedro Gonzalez-Alegre
Journal:  Neurochem Res       Date:  2010-12-16       Impact factor: 3.996

4.  Developmental patterns of torsinA and torsinB expression.

Authors:  Anju Vasudevan; Xandra O Breakefield; Pradeep G Bhide
Journal:  Brain Res       Date:  2006-02-02       Impact factor: 3.252

5.  Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice.

Authors:  Yu Zhao; Michael DeCuypere; Mark S LeDoux
Journal:  Exp Neurol       Date:  2008-01-19       Impact factor: 5.330

6.  Glial elements contribute to stress-induced torsinA expression in the CNS and peripheral nervous system.

Authors:  Y Zhao; J Xiao; M Ueda; Y Wang; M Hines; T S Nowak; M S LeDoux
Journal:  Neuroscience       Date:  2008-05-06       Impact factor: 3.590

Review 7.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

8.  Systematic mutation analysis of seven dystonia genes in complex regional pain syndrome with fixed dystonia.

Authors:  M Florencia Gosso; Annetje M de Rooij; Elisenda Alsina-Sanchis; Jessica T Kamphorst; Johan Marinus; Jacobus J van Hilten; Arn M J M van den Maagdenberg
Journal:  J Neurol       Date:  2010-01-12       Impact factor: 4.849

9.  Dynamic nuclear envelope phenotype in rats overexpressing mutated human torsinA protein.

Authors:  Libo Yu-Taeger; Viktoria Gaiser; Larissa Lotzer; Tina Roenisch; Benedikt Timo Fabry; Janice Stricker-Shaver; Nicolas Casadei; Michael Walter; Martin Schaller; Olaf Riess; Huu Phuc Nguyen; Thomas Ott; Kathrin Grundmann-Hauser
Journal:  Biol Open       Date:  2018-07-23       Impact factor: 2.422

10.  DYT1 knock-in mice are not sensitized against mitochondrial complex-II inhibition.

Authors:  Nicole Bode; Cory Massey; Pedro Gonzalez-Alegre
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.